ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution

Journal of Neuroimmunology

Volumn 186, Issue 1-2, 2007, Pages 193-198

  Castelli, Luca ^a   Comi, Cristoforo ^a,b   Chiocchetti, Annalisa ^a   Nicola, Stefania ^a   Mesturini, Riccardo ^a   Giordano, Mara ^a   D'Alfonso, Sandra ^a   Cerutti, Elisa ^a   Galimberti, Daniela ^c   Fenoglio, Chiara ^c   Tesser, Fabiana ^a,b   Yagi, Junji ^d   Rojo, José Maria ^e   Perla, Franco ^f   Leone, Maurizio ^a,b   Scarpini, Elio ^c   Monaco, Francesco ^a,b   Dianzani, Umberto ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^f S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

ICOS; IL10; Multiple sclerosis

Indexed keywords

INTERLEUKIN 10;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; HAPLOTYPE; HOMOZYGOSITY; HUMAN; ICOS GENE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; REMISSION; T LYMPHOCYTE ACTIVATION;

3' UNTRANSLATED REGIONS; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LINKAGE DISEQUILIBRIUM; MALE; MULTIPLE SCLEROSIS; STATISTICS, NONPARAMETRIC;

EID: 34248673439     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.03.022     Document Type: Article

References (38)

1. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
2. Bretscher P.A. A two-step, two-signal model for the primary activation of precursor helper T cells. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 185-190
3. Compston A., and Coles A. Multiple sclerosis. Lancet 359 (2002) 1221-1231
4. Dong C., and Flavell R.A. Cell fate decision: T-helper 1 and 2 subsets in immune responses. Arthritis. Res. 2 (2000) 179-188
5. Dong C., Nurieva R.I., and Prasad D.V. Immune regulation by novel molecules. Immunol. Res. 28 (2003) 39-48
6. Futamatsu H., Suzuki J., Kosuge H., et al. Attenuation of experimental autoimmune myocarditis by blocking activated T cells through inducible costimulatory molecule pathway. Cardiovasc. Res. 59 (2003) 95-104
7. Galimberti D., Fenoglio C., Clerici R., et al. E-selectin A561C and G98T polymorphisms influence susceptibility and course of multiple sclerosis. J. Neuroimmunol. 165 (2005) 201-205
8. Greve B., Vijayakrishnan L., Kubal A., et al. The diabetes susceptibility locus Idd5.1 on mouse chromosome 1 regulates ICOS expression and modulates murine experimental autoimmune encephalomyelitis. J. Immunol. 173 (2004) 157-163
9. Haimila K., Smedberg T., Mustalahti K., et al. Genetic association of celiac disease susceptibility to polymorphisms in the ICOS gene on chromosome 2q33. Genes Immun. 5 (2004) 85-92
10. Hutloff A., Dittrich A.M., Beier K.C., et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397 (1999) 263-266
11. Hutloff A., Buchner K., Reiter K., et al. Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus. Arthritis Rheum. 50 (2004) 3211-3220
12. Keir M.E., and Sharpe A.H. The B7/CD28 costimulatory family in autoimmunity. Immunol. Rev. 204 (2005) 128-143
13. Kroner A., Mehling M., Hemmer B., et al. A PD-1 polymorphism is associated with disease progression in multiple sclerosis. Ann. Neurol. 58 (2005) 50-57
14. Lorentzen A.R., Celius E.G., Ekstrom P.O., et al. Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients. J. Neuroimmunol. 166 (2005) 197-201
15. Lublin F.D., and Reingold S.C. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 48 (1996) 907-911
16. McDonald W.I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50 (2001) 121-127
17. McGeachy M.J., and Anderton S.M. Cytokines in the induction and resolution of experimental autoimmune encephalomyelitis. Cytokine 32 (2005) 81-84
18. Mesturini R., Nicola S., Chiocchetti A., et al. ICOS cooperates with CD28, IL-2, and IFN-γ and modulates activation of human naïve CD4+ T cells. Eur. J. Immunol. 36 (2006) 2601-2612
19. Nurieva R.I. Regulation of immune and autoimmune responses by ICOS-B7h interaction. Clin. Immunol. 115 (2005) 19-25
20. Okamoto T., Saito S., Yamanaka H., et al. Expression and function of the co-stimulator H4/ICOS on activated T cells of patients with rheumatoid arthritis. J. Rheumatol. 30 (2003) 1157-1163
21. Redoglia V., Dianzani U., Rojo J.M., et al. Characterization of H4: a murine T lymphocyte activation molecule functionally associated with the CD3/TCR. Eur. J. Immunol. 26 (1996) 2781-2789
22. Rottman J.B., Smith T., Tonra J.R., et al. The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE. Nat. Immunol. 2 (2001) 605-611
23. Roxburgh R.H., Seaman S.R., Masterman T., et al. Multiple sclerosis severity score: using disability and disease duration to rate disease severity. Neurology 64 (2005) 1144-1151
24. Scott B.G., Yang H., Tuzun E., et al. ICOS is essential for the development of experimental autoimmune myasthenia gravis. J. Neuroimmunol. 153 (2004) 16-25
25. Shalgi R., Lapidot M., Shamir R., and Pilpel Y. A catalog of stability-associated sequence elements in 3' UTRs of yeast mRNAs. Genome Biol. 6 (2005) R86
26. Sharpe A.H., and Freeman G.J. The B7-CD28 superfamily. Nat. Rev., Immunol. 2 (2002) 116-126
27. Shilling R.A., Pinto J.M., Decker D.C., et al. Cutting edge: polymorphisms in the ICOS promoter region are associated with allergic sensitization and Th2 cytokine production. J. Immunol. 175 (2005) 2061-2065
28. Sospedra M., and Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23 (2005) 683-747
29. Sporici R.A., Beswick R.L., von Allmen C., et al. ICOS ligand costimulation is required for T-cell encephalitogenicity. Clin. Immunol. 100 (2001) 277-288
30. Trojano M., Avolio C., Manzari C., et al. Multivariate analysis of predictive factors of multiple sclerosis course with a validated method to assess clinical events. J. Neurol. Neurosurg. Psychiatry 58 (1995) 300-306
31. Vieira P.L.L., Wassink L.M., Smith S., et al. ICOS-mediated signaling regulates cytokine production by human T cells and provides a unique signal to selectively control the clonal expansion of Th2 helper cells. Eur. J. Immunol. 34 (2004) 1282-1290
32. Vinuesa C.G., Cook M.C., Angelucci C., et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435 (2005) 452-458
33. Vyse T.J., and Todd J.A. Genetic analysis of autoimmune disease. Cell 85 (1996) 311-318
34. Wassink L.P., Vieira L., Smits H.H., et al. ICOS expression by activated human Th cells is enhanced by IL-12 and IL-23: increased ICOS expression enhances the effector function of both Th1 and Th2 cells. J. Immunol. 173 (2004) 1779-1786
35. Weinshenker B.G. The natural history of multiple sclerosis. Neurol. Clin. 13 (1995) 119-146
36. Weinshenker B.G., Bass B., Rice G.P., et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 112 (1989) 133-146
37. Yang J.H., Zhang J., Cai Q., et al. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus. Rheumatology (Oxford) 44 (2005) 1245-1254
38. Zhang J., Weiner H.L., and Hafler D.A. Autoreactive T cells in multiple sclerosis. Int. Rev. Immunol. 9 (1992) 183-201